http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0634172-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
filingDate 1994-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2171434dcf5b097c70287975395e062b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e367f6168f428705c33201059765689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af077c7d9d9674b4ad64a0c88ceaed0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9345adf33d193d6fdca081e9bd97e9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9674430cbc5b310b6176f13696812d00
publicationDate 1995-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0634172-A4
titleOfInvention COMPOSITION FOR DERMATOLOGICAL PREPARATION CONTAINING PROSTACYCLINE AS ACTIVE INGREDIENT.
abstract A dermatologic preparation composition containing as the active ingredient a prostacyclin represented by general formula (I) and/or an enantiomer thereof, wherein R<1> represents hydrogen, C1-C10 linear or branched alkyl, or a monovalent cation; R<2> represents -CH2-CH2-R<21> (wherein R<21> represents optionally substituted C1-C10 linear or branched alkyl, or optionally substituted C2-C10 linear or branched alkenyl or alkynyl) or optionally substituted C3-C10 cycloalkyl; and R<3> and R<4> represent each independently hydroxy or -OC( = O)R<5>, wherein R<5> represents C1-C5 linear or branched alkyl.
priorityDate 1993-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04164034-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0015658-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777

Total number of triples: 28.